Skip to main content
PMC home page
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 1988 Jul;70(4):227–232.

Prognostic markers in acute pancreatitis: can pancreatic necrosis be predicted?

T Leese 1, D Shaw 1, M Holliday 1
PMCID: PMC2498776  PMID: 2458063

Abstract

The value of six prognostic markers was assessed prospectively in 198 attacks of acute pancreatitis with specific attention to their ability to predict pancreatic necrosis. The Imrie Prognostic Score (IPS) was recorded within 48 h of diagnosis. The serum C-reactive protein (CRP) alpha 1 antiprotease (A1AP), alpha 2 macroglobulin (A2M), amylase and white cell count (WCC) were measured on days 1, 3 and 7. When comparing all severe clinical outcomes to mile outcomes, serum CRP concentrations were higher on all three days (P less than 0.02, less than 0.001, less than 0.001), A1AP concentrations were higher on day 3 (P less than 0.05), A2M concentrations were lower on day 7 (P less than 0.01) and WCC was higher on all three days (P less than 0.001, less than 0.001, less than 0.001). Serum amylase concentrations showed no significant differences. None of the measured parameters were helpful in distinguishing patients who subsequently developed pancreatic necrosis from patients who had other severe outcomes. Multivariate analysis revealed that the initial IPS showed greatest independent significance in predicting severe outcome followed by the WCC (days 1 and 7) and CRP (day 3). CRP and WCC may be clinically useful predictors of severe outcome to supplement the initial IPS. These methods are unlikely to distinguish pancreatic necrosis from other severe outcomes, but they may supplement clinical judgment in selecting a high risk group of patients for contrast enhanced computed tomography.

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balldin G., Eddeland A., Ohlsson K. Studies on the role of the plasma protease inhibitors on in vitro C3 activation and in acute pancreatitis. Scand J Gastroenterol. 1981;16(5):603–609. doi: 10.3109/00365528109182018. [DOI] [PubMed] [Google Scholar]
  2. Barrett A. J., Starkey P. M. The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism. Biochem J. 1973 Aug;133(4):709–724. doi: 10.1042/bj1330709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Block S., Maier W., Bittner R., Büchler M., Malfertheiner P., Beger H. G. Identification of pancreas necrosis in severe acute pancreatitis: imaging procedures versus clinical staging. Gut. 1986 Sep;27(9):1035–1042. doi: 10.1136/gut.27.9.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Büchler M., Malfertheiner P., Schoetensack C., Uhl W., Scherbaum W., Beger H. G. Wertigkeit biochemischer und bildgebender Verfahren für Diagnose und Prognose der akuten Pankreatitis--Ergebnisse einer prospektiven klinischen Untersuchung. Z Gastroenterol. 1986 Feb;24(2):100–109. [PubMed] [Google Scholar]
  5. Gewurz H., Mold C., Siegel J., Fiedel B. C-reactive protein and the acute phase response. Adv Intern Med. 1982;27:345–372. [PubMed] [Google Scholar]
  6. Imrie C. W., Benjamin I. S., Ferguson J. C., McKay A. J., Mackenzie I., O'Neill J., Blumgart L. H. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978 May;65(5):337–341. doi: 10.1002/bjs.1800650514. [DOI] [PubMed] [Google Scholar]
  7. Kivisaari L., Somer K., Standertskjöld-Nordenstam C. G., Schröder T., Kivilaakso E., Lempinen M. A new method for the diagnosis of acute hemorrhagic-necrotizing pancreatitis using contrast-enhanced CT. Gastrointest Radiol. 1984;9(1):27–30. doi: 10.1007/BF01887796. [DOI] [PubMed] [Google Scholar]
  8. Mayer A. D., McMahon M. J., Bowen M., Cooper E. H. C reactive protein: an aid to assessment and monitoring of acute pancreatitis. J Clin Pathol. 1984 Feb;37(2):207–211. doi: 10.1136/jcp.37.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McMahon M. J., Bowen M., Mayer A. D., Cooper E. H. Relation of alpha 2-macroglobulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg. 1984 Jan;147(1):164–170. doi: 10.1016/0002-9610(84)90052-7. [DOI] [PubMed] [Google Scholar]
  10. Mero M., Schröder T., Tenhunen R., Lempinen M. Serum phospholipase A2, immunoreactive trypsin, and trypsin inhibitors during human acute pancreatitis. Scand J Gastroenterol. 1982 Apr;17(3):413–416. doi: 10.3109/00365528209182078. [DOI] [PubMed] [Google Scholar]
  11. Ohlsson K., Laurell C. B. The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med. 1976 Jul;51(1):87–92. doi: 10.1042/cs0510087. [DOI] [PubMed] [Google Scholar]
  12. Puolakkainen P., Valtonen V., Paananen A., Schröder T. C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut. 1987 Jun;28(6):764–771. doi: 10.1136/gut.28.6.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ranson J. H., Rifkind K. M., Roses D. F., Fink S. D., Eng K., Spencer F. C. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet. 1974 Jul;139(1):69–81. [PubMed] [Google Scholar]
  14. Shatney C. H., Lillehei R. C. Surgical treatment of pancreatic pseudocysts. Analysis of 119 cases. Ann Surg. 1979 Apr;189(4):386–394. [PMC free article] [PubMed] [Google Scholar]
  15. Tillett W. S., Francis T. SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS. J Exp Med. 1930 Sep 30;52(4):561–571. doi: 10.1084/jem.52.4.561. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES